President's Cancer Panel

Promoting Value, Affordability, and Innovation in Cancer Drug Treatment


Innovative new drugs have improved outcomes for many cancer patients. However, spending on cancer drugs has increased dramatically in recent years, far outpacing growth in spending on other components of cancer care. Rising drug costs are a burden on cancer patients and are straining health system and societal resources. In this report, the President’s Cancer Panel presents recommendations for ensuring alignment of drug prices with their value, promoting use of high-value drugs, and supporting continued innovation in cancer drug development.

Click here to start reading at the beginning or choose a section below. Click here to learn more about the President's Cancer Panel.

The Rising Cost of Cancer Drugs: Impact on Patients and Society